The distribution and dosimetry of 111-IN-bleomycin in man

Abstract

The distribution of 111-In in the human body was studied after the injection of -111-In-bleomycin for tumour localization. Uptake in body organs was measured by quantitative scanning using a dual detector scanner. The estimated absorbed dose from an injection of 1 mCi was 0.3 rad to the whole body, and approximately 1 rad to bone marrow, kidneys, liver and spleen.